Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Environmentally induced, occupational diseases with emphasis on chronic kidney disease of multifactorial origin affecting tropical countries.

Annals of occupational and environmental medicine

Wimalawansa SA, Wimalawansa SJ.
PMID: 27499855
Ann Occup Environ Med. 2016 Aug 05;28:33. doi: 10.1186/s40557-016-0119-y. eCollection 2016.

BACKGROUND: Environmentally induced, occupational diseases are increasing worldwide, especially in rural agricultural communities. Poverty-associated malnutrition, environmental hazards and pollution, and lack of access to clean water, safe sanitation, and modern healthcare facilities are often associated with these chronic illnesses.METHOD:...

Cite
Wimalawansa SA, Wimalawansa SJ. Environmentally induced, occupational diseases with emphasis on chronic kidney disease of multifactorial origin affecting tropical countries. Ann Occup Environ Med. 2016;28:33doi: 10.1186/s40557-016-0119-y.
Wimalawansa, S. A., & Wimalawansa, S. J. (2016). Environmentally induced, occupational diseases with emphasis on chronic kidney disease of multifactorial origin affecting tropical countries. Annals of occupational and environmental medicine, 2833. https://doi.org/10.1186/s40557-016-0119-y
Wimalawansa, Shehani A, and Wimalawansa, Sunil J. "Environmentally induced, occupational diseases with emphasis on chronic kidney disease of multifactorial origin affecting tropical countries." Annals of occupational and environmental medicine vol. 28 (2016): 33. doi: https://doi.org/10.1186/s40557-016-0119-y
Wimalawansa SA, Wimalawansa SJ. Environmentally induced, occupational diseases with emphasis on chronic kidney disease of multifactorial origin affecting tropical countries. Ann Occup Environ Med. 2016 Aug 05;28:33. doi: 10.1186/s40557-016-0119-y. eCollection 2016. PMID: 27499855; PMCID: PMC4974668.
Copy Download .nbib Format: NLM
The mechanism of bone resorption by cyclosporin: involvement of the NO-cGMP pathway.

Journal of musculoskeletal & neuronal interactions

Wimalawansa SM, Shankar VS, Simmins DJ, Wimalawansa SJ.
PMID: 15758508
J Musculoskelet Neuronal Interact. 2000 Dec;1(2):141-3.

Treatment with cyclosporin A (CsA) following solid organ transplantations such as heart or liver generally results in bone loss. However, in vitro studies show that CsA inhibits bone resorption. Our previous in vivo animal studies demonstrated that the effects...

Cite
Wimalawansa SM, Shankar VS, Simmins DJ, et al. The mechanism of bone resorption by cyclosporin: involvement of the NO-cGMP pathway. J Musculoskelet Neuronal Interact. 2000;1(2):141-3
Wimalawansa, S. M., Shankar, V. S., Simmins, D. J., & Wimalawansa, S. J. (2000). The mechanism of bone resorption by cyclosporin: involvement of the NO-cGMP pathway. Journal of musculoskeletal & neuronal interactions, 1(2), 141-3.
Wimalawansa, S M, et al. "The mechanism of bone resorption by cyclosporin: involvement of the NO-cGMP pathway." Journal of musculoskeletal & neuronal interactions vol. 1,2 (2000): 141-3.
Wimalawansa SM, Shankar VS, Simmins DJ, Wimalawansa SJ. The mechanism of bone resorption by cyclosporin: involvement of the NO-cGMP pathway. J Musculoskelet Neuronal Interact. 2000 Dec;1(2):141-3. PMID: 15758508.
Copy Download .nbib Format: NLM
Endocrinological Mechanisms of Depressive Disorders and Ill Health.

Expert review of endocrinology & metabolism

Wimalawansa SJ.
PMID: 30063446
Expert Rev Endocrinol Metab. 2016 Jan;11(1):3-6. doi: 10.1586/17446651.2016.1127755. Epub 2016 Jan 06.

No abstract available.

Cite
Wimalawansa SJ. Endocrinological Mechanisms of Depressive Disorders and Ill Health. Expert Rev Endocrinol Metab. 2016;11(1):3-6doi: 10.1586/17446651.2016.1127755.
Wimalawansa, S. J. (2016). Endocrinological Mechanisms of Depressive Disorders and Ill Health. Expert review of endocrinology & metabolism, 11(1), 3-6. https://doi.org/10.1586/17446651.2016.1127755
Wimalawansa, Sunil J. "Endocrinological Mechanisms of Depressive Disorders and Ill Health." Expert review of endocrinology & metabolism vol. 11,1 (2016): 3-6. doi: https://doi.org/10.1586/17446651.2016.1127755
Wimalawansa SJ. Endocrinological Mechanisms of Depressive Disorders and Ill Health. Expert Rev Endocrinol Metab. 2016 Jan;11(1):3-6. doi: 10.1586/17446651.2016.1127755. Epub 2016 Jan 06. PMID: 30063446.
Copy Download .nbib Format: NLM
Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging.

Biology

Wimalawansa SJ.
PMID: 31083546
Biology (Basel). 2019 May 11;8(2). doi: 10.3390/biology8020030.

Recent advances in vitamin D research indicate that this vitamin, a secosteroid hormone, has beneficial effects on several body systems other than the musculoskeletal system. Both 25 dihydroxy vitamin D [25(OH)

Cite
Wimalawansa SJ. Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging. Biology (Basel). 2019;8(2)doi: 10.3390/biology8020030.
Wimalawansa, S. J. (2019). Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging. Biology, 8(2), . https://doi.org/10.3390/biology8020030
Wimalawansa, Sunil J. "Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging." Biology vol. 8,2 (2019). doi: https://doi.org/10.3390/biology8020030
Wimalawansa SJ. Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging. Biology (Basel). 2019 May 11;8(2). doi: 10.3390/biology8020030. PMID: 31083546; PMCID: PMC6627346.
Copy Download .nbib Format: NLM
Sensitive and specific radioreceptor assay for calcitonin gene-related Peptide.

Journal of neuroendocrinology

Wimalawansa SJ.
PMID: 19210477
J Neuroendocrinol. 1989 Feb;1(1):15-9. doi: 10.1111/j.1365-2826.1989.tb00071.x.

Abstract Calcitonin gene-related peptide is a 37-amino-acid neuropeptide which has a direct action on the heart and is an extremely potent vasodilator. Immunoreactive calcitonin gene-related peptide is present in plasma, cerebrospinal fluid and in other tissues. We have previously...

Cite
Wimalawansa SJ. Sensitive and specific radioreceptor assay for calcitonin gene-related Peptide. J Neuroendocrinol. 1989;1(1):15-9doi: 10.1111/j.1365-2826.1989.tb00071.x.
Wimalawansa, S. J. (1989). Sensitive and specific radioreceptor assay for calcitonin gene-related Peptide. Journal of neuroendocrinology, 1(1), 15-9. https://doi.org/10.1111/j.1365-2826.1989.tb00071.x
Wimalawansa, S J. "Sensitive and specific radioreceptor assay for calcitonin gene-related Peptide." Journal of neuroendocrinology vol. 1,1 (1989): 15-9. doi: https://doi.org/10.1111/j.1365-2826.1989.tb00071.x
Wimalawansa SJ. Sensitive and specific radioreceptor assay for calcitonin gene-related Peptide. J Neuroendocrinol. 1989 Feb;1(1):15-9. doi: 10.1111/j.1365-2826.1989.tb00071.x. PMID: 19210477.
Copy Download .nbib Format: NLM
Calcitonin Gene-related Peptide (CGRP) is a Mediator of Vascular Adaptations During Hypertension in Pregnancy.

Trends in endocrinology and metabolism: TEM

Yallampalli C, Wimalawansa SJ.
PMID: 18406251
Trends Endocrinol Metab. 1998 Apr;9(3):113-7. doi: 10.1016/s1043-2760(98)00025-3.

Hypertension during pregnancy is a serious obstetrical problem, and the pathophysiology of pre-eclampsia is unclear. Evidence is presented that calcitonin gene-related peptide (CGRP) plays a role in the vascular adaptations that occur during pregnancy. In addition, CGRP might be...

Cite
Yallampalli C, Wimalawansa SJ. Calcitonin Gene-related Peptide (CGRP) is a Mediator of Vascular Adaptations During Hypertension in Pregnancy. Trends Endocrinol Metab. 1998;9(3):113-7doi: 10.1016/s1043-2760(98)00025-3.
Yallampalli, C., & Wimalawansa, S. J. (1998). Calcitonin Gene-related Peptide (CGRP) is a Mediator of Vascular Adaptations During Hypertension in Pregnancy. Trends in endocrinology and metabolism: TEM, 9(3), 113-7. https://doi.org/10.1016/s1043-2760(98)00025-3
Yallampalli, C, and Wimalawansa, S J. "Calcitonin Gene-related Peptide (CGRP) is a Mediator of Vascular Adaptations During Hypertension in Pregnancy." Trends in endocrinology and metabolism: TEM vol. 9,3 (1998): 113-7. doi: https://doi.org/10.1016/s1043-2760(98)00025-3
Yallampalli C, Wimalawansa SJ. Calcitonin Gene-related Peptide (CGRP) is a Mediator of Vascular Adaptations During Hypertension in Pregnancy. Trends Endocrinol Metab. 1998 Apr;9(3):113-7. doi: 10.1016/s1043-2760(98)00025-3. PMID: 18406251.
Copy Download .nbib Format: NLM
Snapping Extensor Pollicis Longus Tendon Subluxation Secondary to Trapeziometacarpal Instability: Case Report and Technique.

JBJS case connector

Anderson SR, Harrison LM, Wimalawansa SM.
PMID: 33764926
JBJS Case Connect. 2021 Mar 25;11(1). doi: 10.2106/JBJS.CC.20.00478.

CASE: A 20-year-old woman presented with painful, snapping extensor pollicis longus (EPL) tendon subluxation and trapeziometacarpal (TMC) joint instability. Hemi-extensor carpi radialis longus (ECRL) tendon autograft stabilized the TMC joint, reconstructing the 1-2 intermetacarpal ligament. The subluxed EPL tendon...

Cite
Anderson SR, Harrison LM, Wimalawansa SM. Snapping Extensor Pollicis Longus Tendon Subluxation Secondary to Trapeziometacarpal Instability: Case Report and Technique. JBJS Case Connect. 2021;11(1)doi: 10.2106/JBJS.CC.20.00478.
Anderson, S. R., Harrison, L. M., & Wimalawansa, S. M. (2021). Snapping Extensor Pollicis Longus Tendon Subluxation Secondary to Trapeziometacarpal Instability: Case Report and Technique. JBJS case connector, 11(1), . https://doi.org/10.2106/JBJS.CC.20.00478
Anderson, Spencer R, et al. "Snapping Extensor Pollicis Longus Tendon Subluxation Secondary to Trapeziometacarpal Instability: Case Report and Technique." JBJS case connector vol. 11,1 (2021). doi: https://doi.org/10.2106/JBJS.CC.20.00478
Anderson SR, Harrison LM, Wimalawansa SM. Snapping Extensor Pollicis Longus Tendon Subluxation Secondary to Trapeziometacarpal Instability: Case Report and Technique. JBJS Case Connect. 2021 Mar 25;11(1). doi: 10.2106/JBJS.CC.20.00478. PMID: 33764926.
Copy Download .nbib Format: NLM
Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by NG-nitro-Lmethyl ester.

Human reproduction (Oxford, England)

Yallampalli C, Dong YL, Wimalawansa SJ.
PMID: 8671348
Hum Reprod. 1996 Apr;11(4):895-9.

We recently established that the chronic inhibition of nitric oxide production with NG-nitro-L-arginine methyl ester (L-NAME) increases blood pressure and fetal mortality in pregnant rats. Using this animal model, we have investigated whether calcitonin gene-related peptide (CGRP) can reverse...

Cite
Yallampalli C, Dong YL, Wimalawansa SJ. Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by NG-nitro-Lmethyl ester. Hum Reprod. 1996;11(4):895-9
Yallampalli, C., Dong, Y. L., & Wimalawansa, S. J. (1996). Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by NG-nitro-Lmethyl ester. Human reproduction (Oxford, England), 11(4), 895-9.
Yallampalli, et al. "Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by NG-nitro-Lmethyl ester." Human reproduction (Oxford, England) vol. 11,4 (1996): 895-9.
Yallampalli C, Dong YL, Wimalawansa SJ. Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by NG-nitro-Lmethyl ester. Hum Reprod. 1996 Apr;11(4):895-9. PMID: 8671348.
Copy Download .nbib Format: NLM
Circadian variation of plasma calcitonin gene-related Peptide in man.

Journal of neuroendocrinology

Wimalawansa SJ.
PMID: 19215470
J Neuroendocrinol. 1991 Jun 01;3(3):319-22. doi: 10.1111/j.1365-2826.1991.tb00281.x.

Abstract Calcitonin gene-related peptide (CGRP) is one of the most potent endogenous vasodilator peptides known so far. Almost all clinical studies using or measuring CGRP are conducted during the day, and hence this study was carried out to see...

Cite
Wimalawansa SJ. Circadian variation of plasma calcitonin gene-related Peptide in man. J Neuroendocrinol. 1991;3(3):319-22doi: 10.1111/j.1365-2826.1991.tb00281.x.
Wimalawansa, S. J. (1991). Circadian variation of plasma calcitonin gene-related Peptide in man. Journal of neuroendocrinology, 3(3), 319-22. https://doi.org/10.1111/j.1365-2826.1991.tb00281.x
Wimalawansa, S J. "Circadian variation of plasma calcitonin gene-related Peptide in man." Journal of neuroendocrinology vol. 3,3 (1991): 319-22. doi: https://doi.org/10.1111/j.1365-2826.1991.tb00281.x
Wimalawansa SJ. Circadian variation of plasma calcitonin gene-related Peptide in man. J Neuroendocrinol. 1991 Jun 01;3(3):319-22. doi: 10.1111/j.1365-2826.1991.tb00281.x. PMID: 19215470.
Copy Download .nbib Format: NLM
Stigma of obesity: A major barrier to overcome.

Journal of clinical & translational endocrinology

Wimalawansa SJ.
PMID: 29159086
J Clin Transl Endocrinol. 2014 Jun 18;1(3):73-76. doi: 10.1016/j.jcte.2014.06.001. eCollection 2014 Sep.

No abstract available.

Cite
Wimalawansa SJ. Stigma of obesity: A major barrier to overcome. J Clin Transl Endocrinol. 2014;1(3):73-76doi: 10.1016/j.jcte.2014.06.001.
Wimalawansa, S. J. (2014). Stigma of obesity: A major barrier to overcome. Journal of clinical & translational endocrinology, 1(3), 73-76. https://doi.org/10.1016/j.jcte.2014.06.001
Wimalawansa, Sunil J. "Stigma of obesity: A major barrier to overcome." Journal of clinical & translational endocrinology vol. 1,3 (2014): 73-76. doi: https://doi.org/10.1016/j.jcte.2014.06.001
Wimalawansa SJ. Stigma of obesity: A major barrier to overcome. J Clin Transl Endocrinol. 2014 Jun 18;1(3):73-76. doi: 10.1016/j.jcte.2014.06.001. eCollection 2014 Sep. PMID: 29159086; PMCID: PMC5685031.
Copy Download .nbib Format: NLM
Public health interventions for chronic diseases: cost-benefit modelizations for eradicating chronic kidney disease of multifactorial origin (CKDmfo/ CKDu) from tropical countries.

Heliyon

Wimalawansa SJ.
PMID: 31720441
Heliyon. 2019 Nov 01;5(10):e02309. doi: 10.1016/j.heliyon.2019.e02309. eCollection 2019 Oct.

BACKGROUND: In the mid-1970s, an unusual chronic kidney disease of multifactorial origin (CKDmfo), also known as CKD of unknown aetiology (CKDu), began to manifest in several economically poor, tropical, agricultural countries. This preventable, environmentally induced, occupational disease affects several...

Cite
Wimalawansa SJ. Public health interventions for chronic diseases: cost-benefit modelizations for eradicating chronic kidney disease of multifactorial origin (CKDmfo/ CKDu) from tropical countries. Heliyon. 2019;5(10):e02309doi: 10.1016/j.heliyon.2019.e02309.
Wimalawansa, S. J. (2019). Public health interventions for chronic diseases: cost-benefit modelizations for eradicating chronic kidney disease of multifactorial origin (CKDmfo/ CKDu) from tropical countries. Heliyon, 5(10), e02309. https://doi.org/10.1016/j.heliyon.2019.e02309
Wimalawansa, Sunil J. "Public health interventions for chronic diseases: cost-benefit modelizations for eradicating chronic kidney disease of multifactorial origin (CKDmfo/ CKDu) from tropical countries." Heliyon vol. 5,10 (2019): e02309. doi: https://doi.org/10.1016/j.heliyon.2019.e02309
Wimalawansa SJ. Public health interventions for chronic diseases: cost-benefit modelizations for eradicating chronic kidney disease of multifactorial origin (CKDmfo/ CKDu) from tropical countries. Heliyon. 2019 Nov 01;5(10):e02309. doi: 10.1016/j.heliyon.2019.e02309. eCollection 2019 Oct. PMID: 31720441; PMCID: PMC6838989.
Copy Download .nbib Format: NLM
Revisiting the Cervicodeltopectoral Flap for Reconstruction of Cutaneous Head and Neck Defects: Technique Description and Clinical Presentation Correlates.

The Journal of craniofacial surgery

Parrish AJ, Anderson SR, Mulenga MA, Wimalawansa SM, Kadakia SP.
PMID: 34292242
J Craniofac Surg. 2021 Jul 20; doi: 10.1097/SCS.0000000000007919. Epub 2021 Jul 20.

STUDY DESIGN: Technique Description with clinical presentation Correlates.PURPOSE: Revisit and discuss the advantages of the cervicodeltopectoral flap (CDP) as an alternative to microvascular reconstruction for head and neck cutaneous defects.METHODS: Retrospective chart review was performed on 2 patients with...

Cite
Parrish AJ, Anderson SR, Mulenga MA, et al. Revisiting the Cervicodeltopectoral Flap for Reconstruction of Cutaneous Head and Neck Defects: Technique Description and Clinical Presentation Correlates. J Craniofac Surg. 2021;doi: 10.1097/SCS.0000000000007919.
Parrish, A. J., Anderson, S. R., Mulenga, M. A., Wimalawansa, S. M., & Kadakia, S. P. (2021). Revisiting the Cervicodeltopectoral Flap for Reconstruction of Cutaneous Head and Neck Defects: Technique Description and Clinical Presentation Correlates. The Journal of craniofacial surgery, . https://doi.org/10.1097/SCS.0000000000007919
Parrish, Andrew J, et al. "Revisiting the Cervicodeltopectoral Flap for Reconstruction of Cutaneous Head and Neck Defects: Technique Description and Clinical Presentation Correlates." The Journal of craniofacial surgery vol. (2021). doi: https://doi.org/10.1097/SCS.0000000000007919
Parrish AJ, Anderson SR, Mulenga MA, Wimalawansa SM, Kadakia SP. Revisiting the Cervicodeltopectoral Flap for Reconstruction of Cutaneous Head and Neck Defects: Technique Description and Clinical Presentation Correlates. J Craniofac Surg. 2021 Jul 20; doi: 10.1097/SCS.0000000000007919. Epub 2021 Jul 20. PMID: 34292242.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries